Janus Henderson International Core Alpha ETF
JINT - ETF AI Analysis
Top Page
Janus Henderson International Core Alpha ETF (JINT)
JINT, the Janus Henderson International Core Alpha ETF, earns a solid overall rating thanks to strong, diversified holdings like Novartis, BBVA, and Otsuka, which combine robust financial performance, reasonable valuations, and generally positive technical trends. Some positions such as Allianz and BHP face short-term bearish or weaker technical momentum, which can temper returns, and several holdings show potential overvaluation or overbought conditions. The main risk factor is exposure to stocks with stretched valuations or overbought technical signals, which could lead to short-term corrections even though the underlying businesses are generally strong.
JINT vs. SPDR S&P 500 ETF (SPY)
- AUM
- 9.94M
- Region
- Developed Markets
- Expense Ratio
- 0.35%
- Beta
- 0.55
- Issuer
- Janus Henderson
- Inception Date
- Sep 15, 2026
- Dividend Yield
- N/A
- Asset Class
- Equity
- Index Tracked
- No Underlying Index
JINT Summary
JINT is the Janus Henderson International Core Alpha ETF, which follows a broad international stock market theme outside the U.S. It invests in many types of companies across countries like Japan, the UK, France, and Australia, aiming for long-term growth through global diversification. The fund holds well-known names such as Novartis and Shell, giving investors exposure to health care, energy, financials, and more in a single investment. Someone might consider JINT to spread their money across many international markets instead of picking individual foreign stocks. A key risk is that global stock prices can go up and down, and foreign markets and currencies can be volatile.
How much will it cost me?
This ETF has an expense ratio of 0.35%, which means you’ll pay about $3.50 per year for every $1,000 invested. That’s a bit higher than the average low-cost index ETF because JINT is actively managed, with managers selecting international stocks to try to outperform the market.
What would affect this ETF?
JINT could benefit if developed markets outside the U.S. grow steadily, global trade remains strong, and sectors like financials, materials, and energy gain from higher commodity demand and stable interest rates, supporting top holdings such as major banks, miners, and energy companies. On the downside, slower economic growth in Europe or Asia, falling commodity prices, stricter regulations on financials or tobacco, or currency swings versus the U.S. dollar could hurt returns and add volatility to this broad international portfolio.
JINT Top 10 Holdings
JINT is leaning on a mix of defensive giants and global cyclicals to power returns. Novartis is one of the fund’s key engines, with its steady, rising trend helping smooth out bumps elsewhere. Fast Retailing and Japan Tobacco are also climbing, giving the portfolio a consumer tilt that’s working in its favor. On the other side, miners like BHP and Rio Tinto have been lagging lately, acting as a bit of a brake. With holdings spread across Europe, Japan, and other developed markets outside the U.S., the ETF offers broad international exposure without a single dominant sector calling the shots.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Novartis AG | 3.25% | $323.26K | CHF 245.40B | 26.78% | 80Outperform | |
| Shell (UK) | 2.86% | $283.60K | GBP 210.62B | 30.08% | 73Outperform | |
| Allianz | 2.41% | $239.21K | EUR 177.73B | 31.32% | 67Neutral | |
| BHP Group Ltd | 2.26% | $224.77K | AUD 299.21B | 35.84% | 68Neutral | |
| British American Tobacco | 2.23% | $221.48K | GBP 100.01B | 12.27% | 71Outperform | |
| Banco Bilbao Vizcaya Argentaria | 2.04% | $202.54K | EUR 129.55B | 24.84% | 76Outperform | |
| FAST RETAILING CO | 2.03% | $201.40K | JPY 25.81T | 44.02% | 74Outperform | |
| AXA SA | 1.90% | $188.74K | EUR 96.96B | 20.92% | 75Outperform | |
| Astellas Pharma | ― | ― | ― | ― | 69Neutral |
JINT Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For JINT, the sentiment is Positive. The current price of 24.90 is below the 20-day moving average (MA) of 24.94, compared to the 50-day MA of , and compared to the 200-day MA of , indicating a neutral trend. The MACD of -0.04 indicates Positive momentum. The RSI at 48.70 is Neutral, neither overbought nor oversold. The STOCH value of 46.81 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JINT.
JINT Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| $24.90 | $27.00(8.44% Upside) | $9.94M | 0.35% | 67Neutral | |
| $40.27 | $46.12(14.53% Upside) | $94.65M | 0.45% | 66Neutral | |
| $27.42 | $32.15(17.26% Upside) | $20.53M | 0.42% | 66Neutral | |
| $26.37 | ― | $20.46M | 0.99% | 67Neutral | |
| $30.80 | $37.50(21.75% Upside) | $18.53M | 0.55% | 66Neutral | |
| $25.15 | $28.57(13.61% Upside) | $6.89M | 0.54% | 64Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JINT | Janus Henderson International Core Alpha ETF | 24.90 | -0.27 | -1.05% | |
| INEQ | Columbia International Equity Income Etf | 40.27 | 5.63 | 16.25% | |
| RWIN | Rayliant NxtGen Multifactor International Equity ETF | 27.42 | 1.70 | 6.61% | |
| LCIV | Logan Capital International ETF | 26.37 | 1.54 | 6.20% | |
| FFDI | Fidelity Fundamental Developed International ETF | 30.80 | 1.94 | 6.73% | |
| PRXI | Praxis Impact International ETF | 25.15 | 0.78 | 3.19% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
